Familial hypercholesterolemia (FH) is an inherited disorder of lipoprotein metabolism involving mutations in the LDL receptor (LDL-R). Patients with mutation in one (heterozygous) or both (homozygous) genes have markedly elevated LDL cholesterol and are at increased risk for coronary heart disease (
The effect of LDL apheresis on progression of coronary artery disease in patients with familial hypercholesterolemia
✍ Scribed by Waidner, T. ;Franzen, D. ;Voelker, W. ;Ritter, M. ;Borberg, H. ;Hombach, V. ;H�pp, H.W. ;,
- Publisher
- Springer-Verlag
- Year
- 1994
- Tongue
- English
- Weight
- 592 KB
- Volume
- 72
- Category
- Article
- ISSN
- 1432-1440
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The purpose of this study was to determine whether a single LDL apheresis would improve impaired endothelium‐dependent dilation of the coronary artery in patients with hypercholesterolemia. Hypercholesterolemia is associated with impaired endothelial function, and human studies using ch
Atrial natriuretic peptide (ANP or NPPA) is the precursor protein of the form of amyloidosis called isolated atrial amyloid (IAA), which is related to the increased incidence of cardiac pathological conditions with age. Familial hypercholesterolemia (FH) patients are characterized by high concentrat
## Abstract Recently very potent extracorporeal cholesterol‐lowering treatment options have become available for patients with hypercholesterolemia. LDL immunoapheresis treatment selectively removes LDL and lipoprotein(a) from the circulation. Since LDL is the major carrier of lipophilic antioxidan